{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:43:49Z","timestamp":1789425829995,"version":"build-2803163510"},"reference-count":40,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T00:00:00Z","timestamp":1643500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Background: Cutaneous squamous cell carcinoma (cSCC) is one of the most devastating complications of recessive dystrophic epidermolysis bullosa (RDEB). We recently demonstrated a reduction in immune cell peritumoral infiltration in RDEB patients with cSCC, together with a reduction in CD3+, CD4+, CD68+ and CD20 lymphocytes as compared to primary and secondary cSCC in patients without RDEB. Recently, new molecules, such as high mobility group box 1 (HMGB1), T cell immunoglobulin, mucin domain 3 (TIM-3) and Heme oxygenase-1 (HO-1), have been shown to play a role in antitumoral immunity. Objective: Patients with RDEB are known to be at increased risk of developing skin cancers, including the dreaded squamous cell carcinoma of the. Tendentially, cSCCs that arise in the context of EBDR are more aggressive and lead to statistically significant bad outcomes compared to cSCCs developed on the skin of patients without EBDR. In an attempt to study the microenvironment of these lesions, we conducted an immunohistochemical analysis study of proteins that could be actively involved in the genesis of this type of malignant neoplasms. Methods: In this retrospective study, the OH1-HMGB1-TIM3 activation axis, as correlated to the T lymphocytes cell count, was assessed in biopsy samples from 31 consecutive cases consisting of 12 RDEB patients with cSCC, 12 patients with primary cSCC and 7 RDEB patients with pseudoepitheliomatous cutaneous hyperplasia. Parametric Student\u2019s t-test was applied for normally distributed values, such as CD4+ and CD8+, and non-parametric Mann\u2013Whitney test for non-normally distributed values, such as HMGB-1, TIM-3 and HO-1. Results: In RDEB patients with cSCC and with pseudoepitheliomatous hyperplasia, the expression of CD4 T helper lymphocytes was lower than in the peritumoral infiltrate found in primary cSCC. CD8 cytotoxic T lymphocytes were increased in primary cSCC compared to the other two groups. An increased HMGB1 expression was evident in both primary and RDEB cSCC. TIM3 expression was higher in RDEB patients with cSCC compared to the other two groups. A significantly reduced immunohistochemical expression of HO-1 was evident in the tumoral microenvironment of cSCC-RDEB as compared to primary cSCC. Conclusions: These data suggest that a reduced immune cell peritumoral infiltration in RDEB patients could be responsible, in the complexity of the mechanisms of carcinogenesis and host response, of the particular aggressiveness of the cSCC of RDEB patients, creating a substrate for greater local immunosuppression, which, potentially, can \u201copen the doors\u201d to development and eventual metastasis by this malignant neoplasm.<\/jats:p>","DOI":"10.3390\/life12020213","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T01:46:08Z","timestamp":1643593568000},"page":"213","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immune Disregulation in Cutaneous Squamous Cell Carcinoma of Patients with Recessive Dystrophic Epidermolysis Bullosa: A Single Pilot Study"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9790-5361","authenticated-orcid":false,"given":"Angela","family":"Filoni","sequence":"first","affiliation":[{"name":"Section of Dermatology, Department of Biomedical Science and Human Oncology (DIMO), University of Bari \u2018Aldo Moro\u2019, Piazza Giulio Cesare 11, 70121 Bari, Italy"},{"name":"Section of Dermatology, Perrino Hospital, S.S.7, 72100 Brindisi, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerolamo","family":"Cicco","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Biomedical Science and Human Oncology (DIMO), University of Bari \u2018Aldo Moro\u2019, Piazza Giulio Cesare 11, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0325-4316","authenticated-orcid":false,"given":"Gerardo","family":"Cazzato","sequence":"additional","affiliation":[{"name":"Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari \u2018Aldo Moro\u2019, Piazza Giulio Cesare 11, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bosco","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Biomedical Science and Human Oncology (DIMO), University of Bari \u2018Aldo Moro\u2019, Piazza Giulio Cesare 11, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Lospalluti","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Biomedical Science and Human Oncology (DIMO), University of Bari \u2018Aldo Moro\u2019, Piazza Giulio Cesare 11, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4008-4897","authenticated-orcid":false,"given":"Marco","family":"Tucci","sequence":"additional","affiliation":[{"name":"Section of Medical Oncology, Department of Biomedical Sciences and Clinical Oncology (DIMO), University of Bari \u2018Aldo Moro\u2019, Piazza Giulio Cesare 11, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Cimmino","sequence":"additional","affiliation":[{"name":"Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari \u2018Aldo Moro\u2019, Piazza Giulio Cesare 11, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Foti","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Biomedical Science and Human Oncology (DIMO), University of Bari \u2018Aldo Moro\u2019, Piazza Giulio Cesare 11, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Marzullo","sequence":"additional","affiliation":[{"name":"Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari \u2018Aldo Moro\u2019, Piazza Giulio Cesare 11, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1319-4946","authenticated-orcid":false,"given":"Domenico","family":"Bonamonte","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Biomedical Science and Human Oncology (DIMO), University of Bari \u2018Aldo Moro\u2019, Piazza Giulio Cesare 11, 70121 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,30]]},"reference":[{"key":"ref_1","first-page":"117","article-title":"Inherited epidermolysis bullosa and squamous cell carcinoma: A systematic review of 117 cases","volume":"20","author":"Chiaverini","year":"2016","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Condorelli, A.G., Dellambra, E., Logli, E., Zambruno, G., and Castiglia, D. (2019). Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives. Int. J. Mol. Sci., 14.","DOI":"10.3390\/ijms20225707"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2017.01.002","article-title":"Stromal microenvironment in type VII collagen-deficient skin: The ground for squamous cell carcinoma development","volume":"63","author":"Guerra","year":"2017","journal-title":"Matrix Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archderm.1992.01680120073006","article-title":"Peripheral blood mononuclear cell subsets in patients with severe inherited forms of epidermolysis bullosa","volume":"128","author":"Chopra","year":"1992","journal-title":"Arch. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/jdv.16022","article-title":"Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: A retrospective study","volume":"34","author":"Filoni","year":"2020","journal-title":"J. Eur. Acad. Derm. Venereol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1189\/jlb.1008585","article-title":"HMGB1 loves company","volume":"86","author":"Bianchi","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jdermsci.2016.12.021","article-title":"Altered balance of epidermis-related chemokines in epidermolysis bullosa","volume":"86","author":"Ujiie","year":"2017","journal-title":"J. Derm. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/exd.12152","article-title":"Serum levels of high mobility group box 1 correlate with disease severity in recessive dystrophic epidermolysis bullosa","volume":"22","author":"Petrof","year":"2013","journal-title":"Exp. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/07357900801954210","article-title":"Overexpression of high mobility group (HMG) B1 and B2 proteins directly correlates with the progression of squamous cell carcinoma in skin","volume":"26","author":"Sharma","year":"2008","journal-title":"Cancer Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/1078-0432.CCR-06-1953","article-title":"Masquerader: High mobility group box-1 and cancer","volume":"15","author":"Ellerman","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imr.12520","article-title":"TIM-3 and its role in regulating anti-tumor immunity","volume":"276","author":"Das","year":"2017","journal-title":"Immunol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Du, W., Yang, M., Turner, A., Xu, C., Ferris, R.L., Huang, J., Kane, L.P., and Lu, B. (2017). TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action. Int. J. Mol. Sci., 16.","DOI":"10.3390\/ijms18030645"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/eji.200939274","article-title":"TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines","volume":"39","author":"Hastings","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101302","DOI":"10.1016\/j.smim.2019.101302","article-title":"Tim3: A co-receptor with diverse roles in T cell exhaustion and tolerance","volume":"42","author":"Tang","year":"2019","journal-title":"Sem. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_17","unstructured":"(2017, October 05). 17. NCCN Clinical Practice Guidelines in Oncology. Squamous Cell Skin Cancer Version 2.2018. NCCN.org. Available online: https:\/\/www.nccn.org\/guidelines\/category_1."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1525-1470.2007.00498.x","article-title":"Increased expression of HMGB-1 in the skin lesions of erythema toxicum","volume":"24","author":"Marchini","year":"2007","journal-title":"Pediatr. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Cazzato, G., Colagrande, A., Cimmino, A., Cicco, G., Scarcella, V.S., Tarantino, P., Lospalluti, L., Romita, P., Foti, C., and Demarco, A. (2021). HMGB1-TIM3-HO1: A New Pathway of Inflammation in Skin of SARS-CoV-2 Patients? A Retrospective Pilot Study. Biomolecules, 16.","DOI":"10.3390\/biom11081219"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/10641955.2019.1688069","article-title":"Immunohistochemical localization of heme oxygenase-1 and bilirubin\/biopyrrin of heme metabolites as antioxidants in human placenta with preeclampsia","volume":"39","author":"Miya","year":"2020","journal-title":"Hypertens. Pregnancy"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1038\/onc.2017.294","article-title":"Acetylation is essential for nuclear heme oxygenase-1-enhanced tumor growth and invasiveness","volume":"7","author":"Hsu","year":"2017","journal-title":"Oncogene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/cup.13123","article-title":"Evaluation of T-lymphocyte subpopulations in actinic keratosis, in situ and invasive squamous cell carcinoma of the skin","volume":"45","author":"Stravodimou","year":"2018","journal-title":"J. Cutan. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e1356148","DOI":"10.1080\/2162402X.2017.1356148","article-title":"The Prognostic role of tumor infiltrating T Lymphocytes in SCC of head and neck: A systematic review and meta-analysis","volume":"6","author":"Ooft","year":"2017","journal-title":"Oncoimmunology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1128\/MCB.23.8.2991-2998.2003","article-title":"Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype","volume":"23","author":"Poser","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-065X.2007.00574.x","article-title":"High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptative immunity","volume":"220","author":"Bianchi","year":"2007","journal-title":"Immunol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4049\/jimmunol.176.1.12","article-title":"Cutting edge: Extracellular high mobility group box-1 protein is a proangiogenic cytokine","volume":"176","author":"Mitola","year":"2006","journal-title":"J. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9440(10)62344-9","article-title":"Angiogenetic signaling through hypoxia: HMGB1: An angiogenetic switch molecule","volume":"166","author":"Schlueter","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.RES.0000257774.55970.f4","article-title":"High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells","volume":"100","author":"Chavakis","year":"2007","journal-title":"Circ. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.immunol.021908.132603","article-title":"HMGB1 and RAGE in Inflammation and Cancer","volume":"28","author":"Sims","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"ref_30","first-page":"68","article-title":"HMGB1: The central cytokine for all lymphoid cells","volume":"4","author":"Guanquiao","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Weng, H., Deng, Y., Xie, Y., Liu, H., and Gong, F. (2013). Expression and significance of HMGB1, TLR4 and NF-kB p65 in human epidermal tumors. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-311"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1016\/j.ejca.2010.07.016","article-title":"Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance","volume":"46","author":"Liu","year":"2010","journal-title":"EJC"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1038\/ncomms6932","article-title":"Innate sensing of microbial products promotes wound-induced skin cancer","volume":"6","author":"Hoste","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-4362.1992.tb03518.x","article-title":"Differentiation of bullous pemphigoid from epidermolysis bullosa acquisita on frozen skin biopsies","volume":"31","author":"Valeski","year":"1992","journal-title":"Int. J. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.celrep.2019.10.104","article-title":"Epithelial HMGB1 Delays Skin Wound Healing and Drives Tumor Initiation by Priming Neutrophils for NET Formation","volume":"29","author":"Hoste","year":"2019","journal-title":"Cell Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/hep.26938","article-title":"Liver-primed CD8+ T cells suppress antiviral adaptative immunity througt galectin9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice","volume":"59","author":"Dolina","year":"2014","journal-title":"Hepatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/ni.2396","article-title":"Tumor immunity times out: TIM-3 and HMGB1","volume":"13","author":"Tang","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/08916930701356978","article-title":"HMGB1: A signal of necrosis","volume":"40","author":"Raucci","year":"2007","journal-title":"Autoimmunity"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.arcmed.2017.10.007","article-title":"Hemin Reduces HMGB1 Release by UVB in an AMPK\/HO-1-dependent Pathway in Human Keratinocytes HaCaT Cells","volume":"48","author":"Park","year":"2017","journal-title":"Arch. Med. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.freeradbiomed.2011.07.025","article-title":"Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice","volume":"51","author":"Was","year":"2011","journal-title":"Free Radic. Biol. Med."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/2\/213\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:11:19Z","timestamp":1760134279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/2\/213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,30]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["life12020213"],"URL":"https:\/\/doi.org\/10.3390\/life12020213","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,30]]}}}